BioSpace News Archive

The U.S. cath labs market is likely to gain upward revenues curve during the assessment period of 2019 to 2029.

The global testosterone replacement therapy market is expected to be influenced by the rising awareness about the diseases itself.

The demand within the global healthcare e-commerce market is growing on back of continuous advancements in the e-commerce industry and online sales of medication.

Wearable devices and non-invasive are trending in the healthcare sector. Hence, companies are harnessing advantages of wearable devices in fetal monitoring systems.

Ataxia is a degenerative disease of the nervous system, which causes movement disorder. Patients of ataxia have issues while moving parts of body or the muscles in the arms and legs without coordination

Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer, today announced the pricing of its initial public offering of 5,666,667 shares of common stock at a public offering price of $15.00 per share.

Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced the pricing of an underwritten public offering of 2,948,718 shares of its common stock at a public offering price of $39.00 per share.

Synthetic biology market has evolved on the back of surging industry interest worldwide on the profound capabilities it is said to possess, mainly by virtue of redesigning biological components and systems.

Perfusion systems for solid organ preservation are crucial in transplantation and for preclinical research.

Sodium phenylbutyrate drugs are prescribed for adjunctive therapy in the chronic management of urea cycle disorders.